http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31851124

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 1003
issn 0007-0920
1532-1827
issueIdentifier 7
pageRange 996-1003
publicationName British Journal of Cancer
startingPage 996
bibliographicCitation De Santis R, Anastasi AM, D'Alessio V, Pelliccia A, Albertoni C, Rosi A, Leoni B, Lindstedt R, Petronzelli F, Dani M, Verdoliva A, Ippolito A, Campanile N, Manfredi V, Esposito A, Cassani G, Chinol M, Paganelli G, Carminati P. Novel antitenascin antibody with increased tumour localisation for Pretargeted Antibody-Guided RadioImmunoTherapy (PAGRIT). British Journal of Cancer. 2003 Apr 01;88(7):996–1003. doi: 10.1038/sj.bjc.6600818.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cde3c65d37e6e884c29b9c61bc0d669c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e46a7ad1f7c167a41c2cc9e459b201b4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6444d7292f09c11d4d8bde5bea44a75b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_50efb9e08c20124be25f61d175fab306
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_35b7fece9a1b0f444c597d7e73e735a4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_775cb1f78538663ab1828fd381b4c4f7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_add51494f5b5a4fa213ec524c033b103
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_73d094ba61a1963449fbbe5d8896872c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8ba98dd7982e9a357dc181b0c5090eae
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_52660ce64f94288674b101bf7248ccf4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_486a494aa8007dcf4a343f5a3df7af31
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cfbefc62d5ffd7e0f8bbe2654c95aad3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7334264631ee3efec08f6ad5f04d61af
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d1cad578d68648d014e5b7cb374dc0e4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2e5f57928214a7af4c551e97a01cdcef
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_56babff4fab077ff4d1b80d9f874e4ab
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0a6e06385de53848d54d1669da313557
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fa0a6e20ac6eacb7e3d7a81206ee8881
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_83fa2f8a39cdec8b28edaf69f0b75eaf
date 2003-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1038/sj.bjc.6600818
https://pubmed.ncbi.nlm.nih.gov/PMC2376359
https://pubmed.ncbi.nlm.nih.gov/12671694
isPartOf https://portal.issn.org/resource/ISSN/1532-1827
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1765
https://portal.issn.org/resource/ISSN/0007-0920
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://scigraph.springernature.com/
https://www.crossref.org/
title Novel antitenascin antibody with increased tumour localisation for Pretargeted Antibody-Guided RadioImmunoTherapy (PAGRIT)
discusses http://id.nlm.nih.gov/mesh/M0028456
http://id.nlm.nih.gov/mesh/M0001357
hasSubjectTerm http://purl.org/au-research/vocabulary/anzsrc-for/2008/11
http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID171548
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128392536
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128288165
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129071275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128368395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128133749
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128477989
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127573844
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129771248
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129066605
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128364298

Total number of triples: 56.